Apyx Medical CORP 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
Apyx Medical's FY2024 results reveal a focus on cost reduction and strategic adjustments amidst market headwinds, including a revenue decrease and ongoing efforts to achieve cash-flow breakeven.
NASDAQ
Apyx Medical Corporation's 10-K filing for 2023 highlights a year of revenue growth, strategic shifts, and ongoing efforts to navigate regulatory challenges and market dynamics.